Distributor inventory
Glimepiride 2 mg + Metformin hydrochloride 500 mg
Type 2 diabetes mellitus (adult) when blood sugar is not adequately controlled with diet/exercise and/or single antidiabetic therapy; helps control fasting and post‑meal glucose.
Glimepiride (a sulfonylurea) stimulates the pancreas to release insulin and improves peripheral insulin sensitivity. Metformin (a biguanide) reduces hepatic glucose production and decreases intestinal glucose absorption while improving insulin sensitivity, resulting in better overall glycaemic control.
Oral tablet. Take exactly as prescribed, usually once daily with breakfast or the first main meal (sometimes twice daily depending on dose). Swallow whole with water; take with food to reduce stomach upset. Do not skip meals to avoid hypoglycaemia; monitor blood glucose regularly.
Common side effects of AMARYL MV 2MG may include:
May cause hypoglycaemia (risk increases with missed meals, excessive exercise, alcohol, or other antidiabetics); carry sugar source. Use with caution in elderly and in kidney/liver impairment. Metformin rarely can cause lactic acidosis—seek urgent care for rapid breathing, severe weakness, abdominal pain, or unusual sleepiness; avoid in severe renal impairment, dehydration, severe infection, shock, or hypoxia. Temporarily stop metformin before/after iodinated contrast procedures and major surgery as advised. Not for type 1 diabetes or diabetic ketoacidosis.
